Mukka Proteins [MUKKA] vs Britannia Industries [BRITANNIA] Detailed Stock Comparison

Mukka Proteins
NSE
Loading...

Britannia Industries
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Mukka Proteins wins in 5 metrics, Britannia Industries wins in 12 metrics, with 0 ties. Britannia Industries appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Mukka Proteins | Britannia Industries | Better |
---|---|---|---|
P/E Ratio (TTM) | 17.22 | 58.89 | Mukka Proteins |
Price-to-Book Ratio | 1.83 | 29.73 | Mukka Proteins |
Debt-to-Equity Ratio | 99.21 | 28.45 | Britannia Industries |
PEG Ratio | N/A | 66.06 | N/A |
EV/EBITDA | 13.39 | 40.77 | Mukka Proteins |
Profit Margin (TTM) | 4.62% | 12.02% | Britannia Industries |
Operating Margin (TTM) | 6.91% | 14.60% | Britannia Industries |
EBITDA Margin (TTM) | 6.91% | 14.60% | Britannia Industries |
Return on Equity | 11.12% | 49.73% | Britannia Industries |
Return on Assets (TTM) | 5.04% | 24.65% | Britannia Industries |
Free Cash Flow (TTM) | $-1.39B | $21.06B | Britannia Industries |
Dividend Yield | N/A | 2.57% | N/A |
1-Year Return | -41.22% | -6.84% | Britannia Industries |
Price-to-Sales Ratio (TTM) | 0.80 | 7.09 | Mukka Proteins |
Enterprise Value | $12.71B | $1,295.06B | Britannia Industries |
EV/Revenue Ratio | 1.26 | 7.09 | Mukka Proteins |
Gross Profit Margin (TTM) | 16.21% | 39.16% | Britannia Industries |
Revenue per Share (TTM) | $34 | $758 | Britannia Industries |
Earnings per Share (Diluted) | $1.55 | $91.28 | Britannia Industries |
Beta (Stock Volatility) | N/A | 0.53 | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Mukka Proteins vs Britannia Industries Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Mukka Proteins | -3.07% | -1.54% | -7.40% | -11.97% | -21.81% | -32.30% |
Britannia Industries | -1.36% | -5.28% | -7.62% | -4.82% | 8.53% | 11.33% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Mukka Proteins | -41.22% | -36.07% | -36.07% | -36.07% | -36.07% | -36.07% |
Britannia Industries | -6.84% | 45.75% | 37.48% | 233.69% | 2,511.55% | 4,765.11% |
Performance & Financial Health Analysis: Mukka Proteins vs Britannia Industries
Metric | MUKKA | BRITANNIA |
---|---|---|
Market Information | ||
Market Cap | ₹8.01B | ₹1.30T |
Market Cap Category | Small cap | Large cap |
10 Day Avg. Volume | 291,923 | 494,159 |
90 Day Avg. Volume | 261,315 | 320,604 |
Last Close | ₹26.81 | ₹5,302.50 |
52 Week Range | ₹24.75 - ₹51.85 | ₹4,506.00 - ₹6,469.90 |
% from 52W High | -48.29% | -18.04% |
All-Time High | ₹56.56 (Jul 15, 2024) | ₹6,469.90 (Sep 30, 2024) |
% from All-Time High | -52.60% | -18.04% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.48% | 0.09% |
Quarterly Earnings Growth | -0.50% | 0.03% |
Financial Health | ||
Profit Margin (TTM) | 0.05% | 0.12% |
Operating Margin (TTM) | 0.07% | 0.15% |
Return on Equity (TTM) | 0.11% | 0.50% |
Debt to Equity (MRQ) | 99.21 | 28.45 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | ₹14.60 | ₹180.83 |
Cash per Share (MRQ) | ₹1.40 | ₹51.66 |
Operating Cash Flow (TTM) | ₹-1,119,299,968 | ₹27.29B |
Levered Free Cash Flow (TTM) | ₹-1,841,501,312 | ₹21.79B |
Dividends | ||
Last 12-Month Dividend Yield | N/A | 2.57% |
Last 12-Month Dividend | N/A | ₹148.50 |
Valuation & Enterprise Metrics Analysis: Mukka Proteins vs Britannia Industries
Metric | MUKKA | BRITANNIA |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 17.22 | 58.89 |
Forward P/E | N/A | 66.06 |
PEG Ratio | N/A | 66.06 |
Price to Sales (TTM) | 0.80 | 7.09 |
Price to Book (MRQ) | 1.83 | 29.73 |
Market Capitalization | ||
Market Capitalization | ₹8.01B | ₹1.30T |
Enterprise Value | ₹12.71B | ₹1.30T |
Enterprise Value Metrics | ||
Enterprise to Revenue | 1.26 | 7.09 |
Enterprise to EBITDA | 13.39 | 40.77 |
Risk & Other Metrics | ||
Beta | N/A | 0.53 |
Book Value per Share (MRQ) | ₹14.60 | ₹180.83 |
Financial Statements Comparison: Mukka Proteins vs Britannia Industries
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | MUKKA | BRITANNIA |
---|---|---|
Revenue/Sales | ₹3.72B | ₹45.35B |
Cost of Goods Sold | ₹3.12B | ₹27.59B |
Gross Profit | ₹603.49M | ₹17.76B |
Research & Development | N/A | N/A |
Operating Income (EBIT) | ₹263.57M | ₹6.75B |
EBITDA | ₹324.12M | ₹8.09B |
Pre-Tax Income | ₹201.01M | ₹7.01B |
Income Tax | ₹61.01M | ₹1.81B |
Net Income (Profit) | ₹140.00M | ₹5.20B |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | MUKKA | BRITANNIA |
---|---|---|
Cash & Equivalents | ₹30.75M | ₹1.33B |
Total Current Assets | ₹9.26B | ₹39.14B |
Total Current Liabilities | ₹6.11B | ₹36.18B |
Long-Term Debt | ₹35.25M | ₹7.32B |
Total Shareholders Equity | ₹4.57B | ₹43.81B |
Retained Earnings | N/A | ₹40.36B |
Property, Plant & Equipment | ₹858.58M | ₹27.35B |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | MUKKA | BRITANNIA |
---|---|---|
Operating Cash Flow | ₹539.04M | N/A |
Capital Expenditures | ₹-13.88M | N/A |
Free Cash Flow | ₹28.76M | N/A |
Debt Repayment | N/A | N/A |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | MUKKA | BRITANNIA |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 291,923 | 494,159 |
Average Daily Volume (90 Day) | 261,315 | 320,604 |
Shares Outstanding | 300.00M | 240.87M |
Float Shares | 80.50M | 117.62M |
% Held by Insiders | 0.78% | 0.51% |
% Held by Institutions | 0.00% | 0.24% |
Dividend Analysis & Yield Comparison: Mukka Proteins vs Britannia Industries
Metric | MUKKA | BRITANNIA |
---|---|---|
Last 12-Month Dividend | N/A | ₹148.50 |
Last 12-Month Dividend Yield | N/A | 2.57% |
3-Year Avg Annual Dividend | N/A | ₹73.50 |
3-Year Avg Dividend Yield | N/A | 1.42% |
3-Year Total Dividends | N/A | ₹220.50 |
Ex-Dividend Date | N/A | Aug 04, 2025 |